Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: Dose-effect relationship of neostigmine

British Journal of Anaesthesia

Volumn 82, Issue 1, 1999, Pages 61-65

  Fuchs Buder, T ^a   Ziegenfuss T ^a   Lysakowski, K ^b   Tassonyi, E ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Antagonists neuromuscular block, neostigmine; Monitoring, electromyography; Neuromuscular block, vecuronium; Pharmacology, magnesium sulphate

Indexed keywords

MAGNESIUM SULFATE; NEOSTIGMINE; VECURONIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; ELECTROMYOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032896609     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/82.1.61     Document Type: Article

References (26)

1. Giesecke AH, Morris RE, Dalton MD, Stephen CR. Of magnesium, muscle relaxants, toxemic parturients, and cats. Anesth Analg 1968; 47: 689-95
2. James MFM. Clinical use of magnesium infusions in anesthesia. Anesth Analg 1992; 74: 129-36
3. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455-63
4. Hutton JD, James DK, Stirrat GM, Douglas HA, Redman CWG. Management of severe pre-eclampsia and eclampsia by UK consultants. Br J Obstet Gynaecol 1992; 99: 554-6.
5. Gülmezoglu AM, Duley L. Use of anticonvulsants in eclampsia and pre-eclampsia: survey of obstetricans in the United Kingdom and Republic of Ireland. BMJ 1998; 316: 975-6
6. Krendal DA. Hypermagnesemia and neuromuscular transmission. Semin Neurol 1990; 10: 42-5
7. James MFM, Schenk PA, Van der Veen BW. Priming of pancuronium with magnesium. Br J Anaesth 1991; 66: 247-9
8. Lampl E, Dandoy M. Priming of atracurium with magnesium. Br J Anaesth 1993; 70: A139
9. Fuchs-Buder T, Wilder-Smith OHG, Borgeat A, Tassonyi E. Interaction of magnesium sulphate with vecuronium-induced neuromuscular block. Br J Anaesth 1995; 74: 405-9
10. Baraka A, Yazigi A. Neuromuscular interaction of magnesium with succinylcholine-vecuronium sequence in the eclamptic parturient. Anesthesiology 1987; 67: 806-8
11. Kussman B, Shorten G, Uppington J, Comunale ME. Administration of magnesium sulphate before rocuronium: effects on speed of onset and duration of neuromuscular block. Br J Anaesth 1997; 79: 122-4
12. Ahn EK, Bai SJ, Cho BJ, Shin Y-S. The infusion rate of mivacurium and spontaneous neuromuscular recovery in magnesium-treated parturients. Anesth Analg 1998; 86: 523-6
13. Ghoneim MM, Long JP. The interaction between magnesium and other neuromuscular blocking agents. Anesthesiology 1970; 32: 23-7
14. Skaredoff MN, Roaf ER, Datta S. Hypermagnesaemia and anaesthetic management. Can Anaesth Soc J 1982; 29: 35-41
15. Sinatra RS, Philip BK, Naulty S, Ostheimer GW. Prolonged neuromuscular blockade with vecuronium in a patient treated with magnesium sulphate. Anesth Analg 1985; 64: 1220-2
16. Smith CE, Donati F, Bevan DR. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade. Anesthesiology 1989; 71: 37-43
17. Gencarelli PJ, Miller RD. Antagonism of ORG NC 45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine. Br J Anaesth 1982; 54: 53-5
18. Naguib M, Gooma M. Atropine-neostigmine mixture: a dose-response study. Can J Anaesth 1989; 36: 412-17
19. Wright PMC, Hart P, Lau M, et al. The magnitude and time course of vecuronium potentiation by desflurane versus isoflurane. Anesthesiology 1995; 82: 404-11
20. McCourt KC, Mirakhur RK, Kumar RN. Antagonism of rocuronium block in the presence of isoflurane. Br J Anaesth 1998; 80 (Supppl. 1): A438
21. Bevan DR, Donati F, Kopman A. Reversal of neuromuscular blockade. Anesthesiology 1992; 77: 785-805
22. Rupp SM, McChristian JW, Miller RD. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium. Anesthesiology 1986; 64: 711-17
23. Caldewell JE. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium. Anesth Analg 1995; 80: 1168-74
24. Del Castillo J, Engback L. The nature of the neuromuscular block produced by magnesium. J Physiol 1954; 124: 234-41
25. Waud BE, Waud DR. Interaction of calcium and potassium with neuromuscular blocking agents. Br J Anaesth 1980; 52: 863-6
26. Al-Mohaya S, Naguib M, Abdelatif M. Abnormal responses to muscle relaxants in a patient with primary hyperparathyroidism. Anesthesiology 1986; 65: 554-6